Skip to main content
. 2023 Sep 13;61(10):e00426-23. doi: 10.1128/jcm.00426-23

TABLE 3.

Contrived sample testing results for each target and concentration a

Grouping variable(s) Proportion of detected samples out of total samples Two-sided 95% confidence limit
Pathogen type Target (expected) Concentration Fraction % Lower Upper
Bacteria Mycoplasma pneumoniae 3.16× LoD 26/26 100.00 87.13 100.00
0.63× LoD 35/35 100.00 90.11 100.00
Neisseria meningitidis 6.33× LoD 27/27 100.00 87.54 100.00
31.6× LoD 38/38 100.00 90.82 100.00
Streptococcus agalactiae 3.16× LoD 24/25 96.00 80.46 99.29
0.63× LoD 36/36 100.00 90.36 100.00
Streptococcus pyogenes 3.16× LoD 25/25 100.00 86.68 100.00
0.63× LoD 36/36 100.00 90.36 100.00
Virus Enterovirus 3.16× LoD 58/60 96.67 88.64 99.08
Human parechovirus 3.16× LoD 59/59 100.00 93.89 100.00
a

Contrived samples were considered valid if the correct pathogen was detected using the QIAstat-Dx ME Panel assay.